» Articles » PMID: 35492605

The Role of the Melatoninergic System in Circadian and Seasonal Rhythms-Insights From Different Mouse Strains

Overview
Journal Front Physiol
Date 2022 May 2
PMID 35492605
Authors
Affiliations
Soon will be listed here.
Abstract

The melatoninergic system comprises the neurohormone melatonin and its molecular targets. The major source of melatonin is the pineal organ where melatonin is rhythmically produced during darkness. In mammals, melatonin biosynthesis is controlled by the central circadian rhythm generator in the suprachiasmatic nucleus (SCN) and photoreceptors in the retina. Melatonin elicits its function principally through two specific receptors called MT1 and MT2. MT1 is highly expressed in the SCN and the hypophysial pars tuberalis (PT), an important interface for control of seasonal functions. The expression of the MT2 is more widespread. The role of the melatoninergic system in the control of seasonal functions, such as reproduction, has been known for more than 4 decades, but investigations on its impact on the circadian system under normal (entrained) conditions started 2 decades later by comparing mouse strains with a fully functional melatoninergic system with mouse strains which either produce insufficient amounts of melatonin or lack the melatonin receptors MT1 and MT2. These studies revealed that an intact melatoninergic system is not required for the generation or maintenance of rhythmic behavior under physiological entrained conditions. As shown by jet lag experiments, the melatoninergic system facilitated faster re-entrainment of locomotor activity accompanied by a more rapid adaptation of the molecular clock work in the SCN. This action depended on MT2. Further studies indicated that the endogenous melatoninergic system stabilizes the locomotor activity under entrained conditions. Notably, these effects of the endogenous melatoninergic system are subtle, suggesting that other signals such as corticosterone or temperature contribute to the synchronization of locomotor activity. Outdoor experiments lasting for a whole year indicate a seasonal plasticity of the chronotype which depends on the melatoninergic system. The comparison between mice with an intact or a compromised melatoninergic system also points toward an impact of this system on sleep, memory and metabolism.

Citing Articles

Skeletal Phenotyping of Period-1-Deficient Melatonin-Proficient Mice.

Bahlmann O, Taheri S, Spaeth M, Schroder K, Schilling A, Dullin C J Pineal Res. 2024; 76(8):e70020.

PMID: 39697088 PMC: 11656283. DOI: 10.1111/jpi.70020.


Dual sources of melatonin and evidence for different primary functions.

Reiter R, Sharma R, Tan D, Chuffa L, da Silva D, Slominski A Front Endocrinol (Lausanne). 2024; 15:1414463.

PMID: 38808108 PMC: 11130361. DOI: 10.3389/fendo.2024.1414463.


Melatonin/Sericin Wound Healing Patches: Implications for Melanoma Therapy.

Adamiak K, Gaida V, Schafer J, Bosse L, Diemer C, Reiter R Int J Mol Sci. 2024; 25(9).

PMID: 38732075 PMC: 11084828. DOI: 10.3390/ijms25094858.


One seasonal clock fits all?.

Michel S, Kervezee L J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2023; 210(4):641-647.

PMID: 37947808 PMC: 11226558. DOI: 10.1007/s00359-023-01680-4.


Melanogenesis Is Directly Affected by Metabolites of Melatonin in Human Melanoma Cells.

Moller J, Linowiecka K, Gagat M, Brozyna A, Foksinski M, Wolnicka-Glubisz A Int J Mol Sci. 2023; 24(19).

PMID: 37834395 PMC: 10573520. DOI: 10.3390/ijms241914947.


References
1.
Owino S, Sanchez-Bretano A, Tchio C, Cecon E, Karamitri A, Dam J . Nocturnal activation of melatonin receptor type 1 signaling modulates diurnal insulin sensitivity via regulation of PI3K activity. J Pineal Res. 2017; 64(3). PMC: 5843510. DOI: 10.1111/jpi.12462. View

2.
Arendt J, Skene D . Melatonin as a chronobiotic. Sleep Med Rev. 2005; 9(1):25-39. DOI: 10.1016/j.smrv.2004.05.002. View

3.
Brednow K, Korf H . Morphological and immunocytochemical features of the pineal organ of C3H and C57BL mice at different stages of postnatal development. Cell Tissue Res. 1998; 292(3):521-30. DOI: 10.1007/s004410051081. View

4.
Yamazaki S, Numano R, Abe M, Hida A, Takahashi R, Ueda M . Resetting central and peripheral circadian oscillators in transgenic rats. Science. 2000; 288(5466):682-5. DOI: 10.1126/science.288.5466.682. View

5.
Liu J, Clough S, Hutchinson A, Adamah-Biassi E, Popovska-Gorevski M, Dubocovich M . MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective. Annu Rev Pharmacol Toxicol. 2015; 56:361-83. PMC: 5091650. DOI: 10.1146/annurev-pharmtox-010814-124742. View